Disrupting Mitochondrial Electron Transfer Chain Complex I Decreases Immune Checkpoints in Murine and Human Acute Myeloid Leukemic Cells

SIMPLE SUMMARY: Despite all of the advancements made in recent years in the treatment of acute myeloid leukemia (AML), long-term survival is achieved by only 30–40% of AML patients. Thus, new therapeutic strategies are strongly needed. This work confirms the increase in oxidative phosphorylation upo...

Descripción completa

Detalles Bibliográficos
Autores principales: Luna-Yolba, Raquel, Marmoiton, Justine, Gigo, Véronique, Marechal, Xavier, Boet, Emeline, Sahal, Ambrine, Alet, Nathalie, Abramovich, Ifat, Gottlieb, Eyal, Visentin, Virgile, Paillasse, Michael R., Sarry, Jean-Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306173/
https://www.ncbi.nlm.nih.gov/pubmed/34298712
http://dx.doi.org/10.3390/cancers13143499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306173/
https://www.ncbi.nlm.nih.gov/pubmed/34298712
http://dx.doi.org/10.3390/cancers13143499

Ejemplares similares